Polyunsaturated fatty acids potentiate cytotoxicity of cisplatin in A549 cells

Acta Poloniae Pharmaceutica - Drug Research

Volumn 71, Issue 6, 2014, Pages 1060-1065

  Zajdel, Alicja ^a   Wilczok, Adam ^a   Latocha, Małgorzata ^b   Tarkowski, Michał ^a   Kokocińska, Mirosława ^a   Dzierzewicz, Zofia ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Department of Cell Biology ^*  (Poland)

Author keywords

Apoptosis; Autophagy; Cisplatin; Polyunsaturated fatty acids

Indexed keywords

ARACHIDONIC ACID; CASPASE 3; CASPASE 7; CISPLATIN; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; ANTINEOPLASTIC AGENT;

A549 CELL LINE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; AUTOLYSOSOME; AUTOPHAGOSOME; AUTOPHAGY; CELL VACUOLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; ENZYME ACTIVITY; FLUORESCENCE; HUMAN; HUMAN CELL; XTT ASSAY; CELL SURVIVAL; CULTURE TECHNIQUE; DOSE RESPONSE; DRUG EFFECTS; DRUG POTENTIATION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ARACHIDONIC ACID; AUTOPHAGY; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; DOCOSAHEXAENOIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; EICOSAPENTAENOIC ACID; HUMANS;

EID: 84919933420     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Siddik Z.H.: Oncogene 22, 7265 (2003).
2. Wang D., Lippard S.J.: Nat. Rev. Drug Discov. 4, 307 (2005).
3. Ohmichi M., Hayakawa J., Tasaka K., Kurachi H., Murata Y.: Trends Pharmacol. Sci. 26, 113 (2005).
4. Ren J.H., He W.S., Nong L., Zhu Q.Y., Hu K., Zhang R.G., Huang L.L. et al.: Cancer Biother. Radiopharm. 25, 75 (2010).
5. Mizushima N., Levine B., Cuervo A.M., Klionsky D.J.: Nature 451, 1069 (2008).
6. Chen N., Karantza-Wadsworth V.: Biochim. Biophys. Acta 1793, 1516 (2009).
7. Yang Z.J., Chee C.E., Huang S., Huang S., Sinicrope F.A.: Mol. Cancer Ther. 10, 1533 (2011).
8. Berquin I.M., Edwards I.J., Chen Y.Q.: Cancer Lett. 269, 363 (2008).
9. Siddiqui R.A., Harvey K., Stillwell W.: Chem. Phys. Lipids 153, 47 (2008).
10. KozubÌk A., Vaculov A., Soucek K., Vondrcek J., Turnek J., Hofmanov J.: Met. Based Drugs 2008, 417897 (2008).
11. Shao Y., Gao Z., Marks P.A., Jiang X.: Proc. Natl. Acad. Sci. USA 101, 18030 (2004)
12. Escrib P.V.: Trends Mol. Med. 12, 34 (2006).
13. Los D. A., Murata N.: Biochim. Biophys. Acta 1666, 142 (2004).
14. Zajdel A., Wilczok A., Gruchlik A., PaduszyÒski P., Dzierøewicz Z.: Adv. Clin. Exp. Med. 19, 585 (2010).
15. Timmer-Bosscha H., Hospers G.A., Meijer C., Mulder N.H., Muskiet F.A., Martini I.A., Uges D.R., de Vries E.G.: J. Natl. Cancer Inst. 81, 1069 (1989).
16. Plumb J.A., Luo W., Kerr D.J.: Br. J. Cancer 67, 728 (1993).
17. El-Mesery M., Al-Gayyar M., Salem H., Darweish M., El-Mowafy A.: Cell Div. 4, 6 (2009).
18. Shin S., Jing K., Jeong S., Kim N., Song K.S., Heo J.Y., Park J.H. et al.: Biomed. Res. Int. 568671, (2013).
19. Serini S., Piccioni E., Merendino N., Calviello G.: Apoptosis 14, 135 (2009).
20. Lee J.S., Lee G.M.: Methods 56, 375 (2012).
21. Klionsky D.J., Abeliovich H., Agostinis P., Agrawal D.K., Aliev G., Askew D.S., Baba M. et al.: Autophagy 4, 151 (2008).
22. Chen Y., Azad M.B., Gibson S.B.: Can. J. Physiol. Pharmacol. 88, 285 (2010).
23. Liu F., Liu D., Yang Y., Zhao S.: Oncol. Lett. 5, 1261 (2013).